|Day's Range||130.75 - 132.24|
|52 Week Range||109.32 - 137.08|
|PE Ratio (TTM)||22.01|
|Dividend & Yield||3.36 (2.53%)|
|1y Target Est||N/A|
GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching more than 30 drug projects to improve returns in its core pharmaceuticals ...
Regardless of how the debate over repealing the Affordable Care Act plays out, there are plenty of reason to like health care as a long-term investment, says Jeff Reeves.
Shares fell after the company's second-quarter results came up short of expectations.